Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce

This study aims to describe an association between the Pfizer-BioNTech (BNT162b2) vaccine and decreased risk of symptomatic and asymptomatic infections with SARS-CoV-2 in hospital employees.

Salvato in:
Dettagli Bibliografici
Pubblicato in:JAMA
Autori principali: Tang, Li, Hijano, Diego R., Gaur, Aditya H., Geiger, Terrence L., Neufeld, Ellis J., Hoffman, James M., Hayden, Randall T.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Medical Association 2021
Soggetti:
Research Letter
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8220512/
https://ncbi.nlm.nih.gov/pubmed/33956050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2021.6564
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi